The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
National Eczema Association
a/k/a: NEA or NEASE
4460 Redwood Highway Suite 16D
San Rafael, CA 94903-1953
The National Eczema Association (NEA) is a non-profit organization dedicated to informing, educating, and providing resources for individuals affected by eczema; increase public awareness of the disease; support research to discover the cause, treatment, and cure of atopic dermatitis-eczema; and represent individuals with eczema in order to help improve their quality of life. Atopic Dermatitis-Eczema is a disease that causes itchy, inflamed skin that most typically affects the insides of the elbows, backs of the knees and the face, but can cover most of the body. NEA was established in 1988 in Portland, Oregon by a group of affected individuals, nurses, doctors, and others concerned with the enormous social, medical, and economic consequences of this disease. A Board of Directors governs NEA. A Scientific Advisory Committee comprised of physicians and scientists who donate their time and expertise guides the Association. Consisting of 3,000 members and eight chapters, the Association produces educational materials including a brochure entitled "All About Atopic Dermatitis," a video entitled "Suffering in Silence," and a newsletter entitled "The Advocate." Programs and activities include a support group, patient advocacy, patient networking, education, and the support of research.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.